Literature DB >> 1505658

Fibrinogen and mechanisms of thrombosis. A difficult link.

G Di Minno1, A Cerbone, M Margaglione, G Vecchione, E Grandone, M Mancini.   

Abstract

Epidemiological observations indicate that high plasma fibrinogen levels are strongly correlated to the frequency of two major thrombotic complications of atherosclerosis: stroke and myocardial infarction. Thrombosis is increasingly recognized as a central mechanism in stroke and myocardial infarction, and fibrinogen is involved in events thought to play a major role in thrombosis. Therefore, elucidation of the relationship between fibrinogen and thrombosis may strengthen the predictive value of this protein and define new interventions against stroke and myocardial infarction. In addition, advances in the understanding of the atherogenic potential of several risk factors of coronary heart disease took advantage of information emerging from the measurement of the factor in population-based studies. Thus, it is conceivable that measuring plasma fibrinogen to predict stroke and myocardial infarction is a major direction to be followed to gain insight into the thrombogenic potential on this protein and inspire new strategies against thrombotic complications of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1505658     DOI: 10.1007/bf00145357

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  34 in total

1.  Binding of fibrinogen to human monocytes.

Authors:  D C Altieri; P M Mannucci; A M Capitanio
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

2.  Hyperreactive platelets and complications of coronary artery disease.

Authors:  J Hirsh
Journal:  N Engl J Med       Date:  1987-06-11       Impact factor: 91.245

Review 3.  Cholesterol and coronary heart disease. A new era.

Authors:  S M Grundy
Journal:  JAMA       Date:  1986-11-28       Impact factor: 56.272

4.  Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study.

Authors:  T W Meade; S Mellows; M Brozovic; G J Miller; R R Chakrabarti; W R North; A P Haines; Y Stirling; J D Imeson; S G Thompson
Journal:  Lancet       Date:  1986-09-06       Impact factor: 79.321

5.  Coordinate expression of macrophage procoagulant and fibrinolytic activity in vitro and in vivo.

Authors:  H A Chapman; Z Vavrin; J B Hibbs
Journal:  J Immunol       Date:  1983-01       Impact factor: 5.422

6.  Pathology of acute myocardial infarction with particular reference to occlusive coronary thrombi.

Authors:  M J Davies; N Woolf; W B Robertson
Journal:  Br Heart J       Date:  1976-07

Review 7.  The use of antithrombotic drugs in artery disease.

Authors:  A S Gallus
Journal:  Clin Haematol       Date:  1986-05

8.  Fibrinogen as a risk factor for stroke and myocardial infarction.

Authors:  L Wilhelmsen; K Svärdsudd; K Korsan-Bengtsen; B Larsson; L Welin; G Tibblin
Journal:  N Engl J Med       Date:  1984-08-23       Impact factor: 91.245

9.  Specific binding of soluble fibrin to macrophages.

Authors:  L A Sherman; J Lee
Journal:  J Exp Med       Date:  1977-01-01       Impact factor: 14.307

10.  Human monocytes are associated with the formation of fibrin.

Authors:  N Hogg
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

View more
  1 in total

1.  Linkage study of fibrinogen levels: the Strong Heart Family Study.

Authors:  Lyle G Best; Kari E North; Xia Li; Vittorio Palmieri; Jason G Umans; Jean MacCluer; Sandy Laston; Karin Haack; Harald Goring; Vincent P Diego; Laura Almasy; Elisa T Lee; Russell P Tracy; Shelley Cole
Journal:  BMC Med Genet       Date:  2008-08-12       Impact factor: 2.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.